Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 1/2005

01.01.2005 | Brief Report

Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin

verfasst von: C. Corpelet, P. Vacher, F. Coudore, H. Laurichesse, N. Conort, B. Souweine

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Excerpt

Reported here is a case of life-threatening infection due to Babesia divergens that was initially treated with quinine and clindamycin, but in which quinine was discontinued after the patient developed severe cardiac toxicity. Despite the fact that therapeutic levels of quinine were not reached prior to discontinuation, the patient recovered on clindamycin therapy. …
Literatur
1.
Zurück zum Zitat Beattie JF, Michelson ML, Holman PJ (2002) Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med 347:697–698 Beattie JF, Michelson ML, Holman PJ (2002) Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med 347:697–698
2.
Zurück zum Zitat Homer MJ, Aguilar-Delfin I, Telford SR VIII, Krause PJ, Persing DH (2000) Babesiosis. Clin Microbiol Rev 13:451–469CrossRefPubMed Homer MJ, Aguilar-Delfin I, Telford SR VIII, Krause PJ, Persing DH (2000) Babesiosis. Clin Microbiol Rev 13:451–469CrossRefPubMed
3.
Zurück zum Zitat Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ (1996) Quinine in the treatment of Babesia divergens infections in humans. Eur J Clin Microbiol Infect Dis 15:840–841 Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ (1996) Quinine in the treatment of Babesia divergens infections in humans. Eur J Clin Microbiol Infect Dis 15:840–841
4.
Zurück zum Zitat Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ (1998) In vitro evaluation of drug susceptibilities of Babesia divergens isolates. Antimicrob Agents Chemother 42:818–820 Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ (1998) In vitro evaluation of drug susceptibilities of Babesia divergens isolates. Antimicrob Agents Chemother 42:818–820
5.
Zurück zum Zitat Denes E, Rogez JP, Dardé ML, Weinbreck P (1999) Management of Babesia divergens babesiosis without a complete course of quinine treatment. Eur J Clin Microbiol Infect Dis 18:672–673 Denes E, Rogez JP, Dardé ML, Weinbreck P (1999) Management of Babesia divergens babesiosis without a complete course of quinine treatment. Eur J Clin Microbiol Infect Dis 18:672–673
6.
Zurück zum Zitat Bateman DN, Blain PG, Woodhouse KW, Rawlins MD, Dyson H, Heyworth R, Prescott LF, Proudfoot AT (1985) Pharmakocinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Quarterly J Med 54:125–131 Bateman DN, Blain PG, Woodhouse KW, Rawlins MD, Dyson H, Heyworth R, Prescott LF, Proudfoot AT (1985) Pharmakocinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Quarterly J Med 54:125–131
Metadaten
Titel
Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin
verfasst von
C. Corpelet
P. Vacher
F. Coudore
H. Laurichesse
N. Conort
B. Souweine
Publikationsdatum
01.01.2005
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2005
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1270-x

Weitere Artikel der Ausgabe 1/2005

European Journal of Clinical Microbiology & Infectious Diseases 1/2005 Zur Ausgabe

Announcements

Announcements

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.